Kiniksa Pharmaceuticals International, plc Stock: price and management transactions · United States · SEC (Form 4)Source id SEC:kiniksa-pharmaceuticals-international-plc-ef6768 US · SEC (Form 4) Mcap €12.8M Follow the Kiniksa Pharmaceuticals International, plc share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €12.8m. The latest transaction was reported on 3 September 2026 (Attribution). Among the most active insiders: Patel Sanj K. The full history is free.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
All Executives205 Thresholds0 Prospectus0 Other0
Declarations 205 total
◆ CHIEF ACCOUNTING OFFICER · Executives · 15 Jul 2026
279 shares @ US$33.50 Class A Ordinary Share SEC:0001464583-26-000008:0
◇ CHIEF ACCOUNTING OFFICER · Executives · 1 Sept 2026
3,932 shares Class A Ordinary Share SEC:0001464583-26-000008:1
◇ CHIEF ACCOUNTING OFFICER · Executives · 1 Sept 2026
2,558 shares Class A Ordinary Share SEC:0001464583-26-000008:2
◇ CHIEF ACCOUNTING OFFICER · Executives · 1 Sept 2026
2,362 shares Class A Ordinary Share SEC:0001464583-26-000008:3
◇ CHIEF ACCOUNTING OFFICER · Executives · 1 Sept 2026
2,644 shares Class A Ordinary Share SEC:0001464583-26-000008:4
● CHIEF ACCOUNTING OFFICER · Executives · 1 Sept 2026
5,531 shares @ US$79.28 Class A Ordinary Share SEC:0001464583-26-000008:5
▼ CHIEF ACCOUNTING OFFICER · Executives · 3 Sept 2026
4,600 shares @ US$80.30 Class A Ordinary Share SEC:0001464583-26-000008:6
◇ CHAIRMAN & CEO · Executives · 1 Sept 2026
9,991 shares Class A Ordinary Share SEC:0001532218-26-000014:0
◇ CHAIRMAN & CEO · Executives · 1 Sept 2026
6,481 shares Class A Ordinary Share SEC:0001532218-26-000014:1
◇ CHAIRMAN & CEO · Executives · 1 Sept 2026
6,237 shares Class A Ordinary Share SEC:0001532218-26-000014:2
◇ CHAIRMAN & CEO · Executives · 1 Sept 2026
8,609 shares Class A Ordinary Share SEC:0001532218-26-000014:3
● CHAIRMAN & CEO · Executives · 1 Sept 2026
15,144 shares @ US$79.28 Class A Ordinary Share SEC:0001532218-26-000014:4
◇ CHAIRMAN & CEO · Executives · 1 Sept 2026
9,991 shares Class A Ordinary Share SEC:0001532218-26-000016:0
◇ CHAIRMAN & CEO · Executives · 1 Sept 2026
6,481 shares Class A Ordinary Share SEC:0001532218-26-000016:1
◇ CHAIRMAN & CEO · Executives · 1 Sept 2026
6,237 shares Class A Ordinary Share SEC:0001532218-26-000016:2
◇ CHAIRMAN & CEO · Executives · 1 Sept 2026
8,609 shares Class A Ordinary Share SEC:0001532218-26-000016:3
● CHAIRMAN & CEO · Executives · 1 Sept 2026
15,144 shares @ US$79.28 Class A Ordinary Share SEC:0001532218-26-000016:4
◇ CHIEF MEDICAL OFFICER · Executives · 1 Sept 2026
2,497 shares Class A Ordinary Share SEC:0001741533-26-000010:0
◇ CHIEF MEDICAL OFFICER · Executives · 1 Sept 2026
1,624 shares Class A Ordinary Share SEC:0001741533-26-000010:1
◇ CHIEF MEDICAL OFFICER · Executives · 1 Sept 2026
1,750 shares Class A Ordinary Share SEC:0001741533-26-000010:2
◇ CHIEF MEDICAL OFFICER · Executives · 1 Sept 2026
2,457 shares Class A Ordinary Share SEC:0001741533-26-000010:3
● CHIEF MEDICAL OFFICER · Executives · 1 Sept 2026
4,029 shares @ US$79.28 Class A Ordinary Share SEC:0001741533-26-000010:4
◇ CHIEF FINANCIAL OFFICER · Executives · 1 Sept 2026
2,694 shares Class A Ordinary Share SEC:0001835458-26-000012:0
◇ CHIEF FINANCIAL OFFICER · Executives · 1 Sept 2026
1,750 shares Class A Ordinary Share SEC:0001835458-26-000012:1
◇ CHIEF FINANCIAL OFFICER · Executives · 1 Sept 2026
1,591 shares Class A Ordinary Share SEC:0001835458-26-000012:2
25 of 205 declarations
Load more (180 remaining) Acerca de Kiniksa Pharmaceuticals International, plc Kiniksa Pharmaceuticals International, plc es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades autoinmunes e inflamatorias. Cotiza en NASDAQ bajo el ticker KNSA.